Department of Liver Surgery, Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
Anesthesia and Operating Centre, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
Ann Surg Oncol. 2022 Aug;29(8):5189-5201. doi: 10.1245/s10434-022-11757-0. Epub 2022 Apr 19.
The role of hepatic resection (HR) combined with radiofrequency ablation (RFA) versus HR alone remains unclear for patients with multifocal hepatocellular carcinomas (HCCs). The aim of this study was to assess the outcomes of selected patients with moderately advanced multifocal HCCs after HR combined with intraoperative RFA versus HR alone.
A total of 304 selected patients with multifocal HCCs (three or fewer lesions, with the largest lesion > 4.5 cm and the residual lesion[s] ≤ 3 cm) who underwent HR plus RFA (HR+RFA group) or HR alone (HR group) were included. Propensity score matching (PSM) was used to adjust for baseline differences. Multivariable and subgroup analyses estimated the effects of clinical factors on survival.
Both overall survival (OS) and recurrence-free survival (RFS) were comparable between both groups before and after PSM. Subgroup analysis showed that HR was associated with better RFS than HR+RFA for those patients with two tumors, or with all lesions located in the same lobe or without microvascular invasion (MVI) [all p < 0.05]. Moreover, en bloc resection provided a higher RFS than separate resection for those with all lesions in the same lobe (p = 0.039).
For selected patients with moderately advanced multifocal HCCs, HR+RFA may offer similar OS and RFS as HR alone. However, HR may be more suitable for those with two tumors, or with all lesions in the same lobe or without MVI. Moreover, en bloc resection may be recommended for those with all lesions in the same lobe.
对于多灶性肝细胞癌(HCC)患者,肝切除术(HR)联合射频消融(RFA)与单独 HR 的作用仍不清楚。本研究旨在评估 HR 联合术中 RFA 与单独 HR 治疗选择的中晚期多灶性 HCC 患者的结局。
共纳入 304 例多灶性 HCC 患者(三个或更少病灶,最大病灶>4.5cm,残余病灶[s]≤3cm),行 HR 加 RFA(HR+RFA 组)或单独 HR(HR 组)。采用倾向评分匹配(PSM)调整基线差异。多变量和亚组分析估计临床因素对生存的影响。
在 PSM 前后,两组的总生存(OS)和无复发生存(RFS)均无差异。亚组分析显示,对于两个肿瘤、所有病灶位于同一叶或无微血管侵犯(MVI)的患者,HR 与 RFS 优于 HR+RFA(均 p<0.05)。此外,对于所有病灶位于同一叶的患者,整块切除比单独切除具有更高的 RFS(p=0.039)。
对于选择的中晚期多灶性 HCC 患者,HR+RFA 与单独 HR 相比可能提供相似的 OS 和 RFS。然而,HR 可能更适用于两个肿瘤、所有病灶位于同一叶或无 MVI 的患者。此外,对于所有病灶位于同一叶的患者,建议行整块切除。